145 related articles for article (PubMed ID: 33244487)
1. SEVERE HYPERANDROGENISM IN A PREMENOPAUSAL WOMAN WITH AN IMAGING-NEGATIVE LEYDIG CELL TUMOR.
Lubchansky SB; McManus R
AACE Clin Case Rep; 2020; 6(6):e290-e294. PubMed ID: 33244487
[TBL] [Abstract][Full Text] [Related]
2. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
[TBL] [Abstract][Full Text] [Related]
4. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
5. The Use of Ovarian Vein Sampling to Lateralize a Virilizing Leydig Cell Ovarian Tumor.
Baweja K; Shuster S; Awad S
AACE Clin Case Rep; 2023; 9(6):182-185. PubMed ID: 38045790
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
7. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
Cheng V; Doshi KB; Falcone T; Faiman C
Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
[TBL] [Abstract][Full Text] [Related]
8. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
9. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
10. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
11. Ovarian vein sampling, and serum and urine testosterone monitoring in ovarian Leydig cell tumors: A report of two cases.
Whiteley G; Carpinello O; Hill MJ; DeCherney A
Case Rep Womens Health; 2020 Jan; 25():e00159. PubMed ID: 31908972
[TBL] [Abstract][Full Text] [Related]
12. An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report.
Shwana S; Shrikrishnapalasuriyar N; Yin W; Vij M; Kalhan A
touchREV Endocrinol; 2021 Apr; 17(1):75-78. PubMed ID: 35118450
[TBL] [Abstract][Full Text] [Related]
13. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract][Full Text] [Related]
14. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
15. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
16. Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone.
Bahtiyar G; Weiss K; Sacerdote AS
Endocr Pract; 2007 Oct; 13(6):601-8. PubMed ID: 17954415
[TBL] [Abstract][Full Text] [Related]
17. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
Yousaf S; Nizar R; John L; Simpson A
JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
[TBL] [Abstract][Full Text] [Related]
18. Detection of pure Leydig cell ovarian tumor not visible on imaging by selective venous blood sampling in a woman with secondary amenorrhea and hirsutism: A case report.
Oride A; Kanasaki H; Okada H; Kyo S
Case Rep Womens Health; 2021 Apr; 30():e00298. PubMed ID: 33665140
[TBL] [Abstract][Full Text] [Related]
19. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
20. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Azziz R; Bradley EL; Potter HD; Boots LR
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
